A global leader in in vitro diagnostics, the company specializes in developing and manufacturing clinical laboratory systems, reagents, and software. Its innovative solutions in hematology, immunology, and molecular diagnostics make it a key player in the healthcare sector, attracting investor interest due to its steady growth and technological advancements.
1 member of Congress has disclosed 1 trade in Sysmex Corporation (SSMXF), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-09-12 | Greg Gianforte | sell | $50K – $100K |